NIH-funded research R01 grant

Understanding how epigenetics controls sperm cell renewal in males

Official title: Epigenetic control of spermatogonial stem cell self-renewal

Funded at University of Pennsylvania · NIH-11065547 · Data updated 2026-11-12

This study is looking at how a certain factor in our genes helps control the growth of sperm-producing cells in men, which could lead to better understanding and treatments for male fertility issues.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Pennsylvania
NIH-funded
Lab location1 site (Philadelphia, United States)
Project startJune 5, 2023
Project endMarch 31, 2028
Funding year2025
Award (this year)$388,827
NIH project number5R01HD109253-03
Project IDNIH-11065547 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for participation or benefit from this research are adult males experiencing fertility issues or those interested in understanding male reproductive health.

Less likely to help

Patients who are not male or those who do not have concerns related to fertility may not receive benefit from this research.

What this research studies

This research investigates the role of a specific epigenetic factor, DOT1L, in regulating the self-renewal of spermatogonial stem cells (SSCs) in adult males. By using a combination of genetic, chemical, and genomic approaches, the study aims to uncover the mechanisms that balance SSC self-renewal and differentiation, which are crucial for continuous sperm production. The findings could lead to advancements in reproductive health and fertility treatments. Patients may benefit from insights into male fertility and potential therapies derived from this research.

Why it matters

Potential benefit: If successful, this research could lead to new treatments for male infertility and improved understanding of sperm production.

How similar studies have gone: Other research has shown success in understanding stem cell regulation, but the specific focus on DOT1L in SSC self-renewal is a novel approach.

Where this research is happening

  • University of Pennsylvania
    Philadelphia, United States
    Active

Researchers

  • Principal investigator: Wang, Peijing Jeremy — University of Pennsylvania
  • Study coordinator: Wang, Peijing Jeremy

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.